Eurasian Hematology-Oncology Group

http://www.ehog.net/

 

Ph-like ALL Therapy Should Be Different From the Other B-ALL: Targeted Therapy Consequence w/ TKI Are JAK2 Added to the Relapse Regimen or IO Approach

0 views
December 30, 2019
Comments 0
Login to view comments. Click here to Login